Universidade do Sagrado Coração
Bauru, São Paulo, 17011-160, Brazil
NCT Number: NCT06933446
Objective: To assess the acute effect of a myofascial release protocol applied to the adductor muscles of the thigh on functional, biomechanical, and physiological variables. Methods: This study is a randomized, double-blind, two-arm crossover clinical trial that will analyze male water polo athletes aged 16 to 25 years recruited from a sports training center in the city of Bauru. Data related to the following parameters will be collected for the physical evaluation: functional performance, through the jump test; biomechanical, through maximum isometric torque of hip adductors, electromyography of the hip and gluteus medius muscles; and physiological, through the analysis of serum markers of muscle damage and inflammation, and heart rate variability. After the initial evaluation, the participants will be randomly divided into two groups: intervention group and sham group. Then, all participants will perform a game simulation. After the game, the participants will receive the intervention designated for each group. For the intervention group, a manual therapy protocol will be applied, based on myofascial release in the thigh region that presents trigger points. For the Sham group, a manual technique, called classic massage, will be applied, with superficial pressure, used to reach only subcutaneous tissues, without acting on muscles and fascia. This protocol will be repeated at four different times, always after the games. After a washout week, the participants will change groups and the data collection protocol will be applied again.
This study is active but is not currently recruiting participants.
Notify Me16 year–25 year
Male
Interventional
Not applicable
Bauru, São Paulo, 17011-160, Brazil
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A myofascial release protocol, applied to the thigh muscles in post-effort recovery in water polo athletes.
Massagem clássica, com pressão superficial, utilizada para atingir apenas tecidos subcutâneos, sem que haja ação sobre músculos e fáscias
Time frame: From enrollment to the end of treatment at 2 weeks
Time frame: From enrollment to the end of treatment at 2 weeks
Time frame: From enrollment to the end of treatment at 2 weeks
Time frame: From enrollment to the end of treatment at 2 weeks
The markers: creatine kinase (CK; Units of Measure= U/L), lactate dehydrogenase (LDH; Units of Measure= UI/L), myoglobin (Myo; Units of Measure= ng/mL), erythrocyte sedimentation rate (ESR; Units of Measure= mm/h), tumor necrosis factor alpha (TNFA; Units of Measure= Å) will be considered for analysis of muscle damage markers and will be determined through specific kits and following the manufacturer's instructions.
Time frame: From enrollment to the end of treatment at 2 weeks
Heart rate variability (HRV) will be collected, at rest, through a non-invasive method used to measure cardiac autonomic control, to assess the autonomic nervous system (ANS), and the RR interval will be recorded by a portable heart rate monitor.
Time frame: From enrollment to the end of treatment at 2 weeks
To estimate the intensity of the exercise, the method proposed by Foster (1998) will be used, which suggests multiplying the subjective perception of exertion (RPE) of the session by the total duration of the training session (sRPE), with the results expressed in arbitrary units (u.a.). To quantify performance during the game, lactate will be collected at the end of each quarter of the game, through blood collections from the earlobe (25 μL) to analyze the peak lactate concentration ([La-]peak) of the effort.
Luis Gustavo Lizi Jorge
Other
Effect of Release of Trigger Points on Functional Capacity, Biomechanical and Physiological Variables in Recovery After Game Simulation in Water Polo Athletes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03952624
CFS, Cancer
Bethesda, Maryland, United States
View Trial DetailsNCT07572578
Fatigue, Pathological Conditions, Signs and Symptoms
Del Mar, California, United States
View Trial DetailsNCT04533165
Behavior, Cancer
Aurora, Colorado, United States
View Trial DetailsNCT06659627
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Leiden, South Holland, Netherlands
View Trial Details